Partnering

We believe that the best way to help the largest number of patients who suffer from rare genetic diseases is to develop strategic partnerships, research collaborations and licensing arrangements.

The breadth of the PATrOL platform gives us the unique ability to tackle a multitude of genetic diseases. While we intend to advance an extensive pipeline of therapies ourselves, we believe that the best way to help the largest number of patients who suffer from rare genetic diseases is to develop strategic partnerships, research collaborations and licensing arrangements.

We are open to discussing opportunities to utilize our PATrOL platform across multiple organ systems and disease indications. Please contact partnerships@neubasetherapeutics.com if you are interested in learning more.